A multi-million rand investment in a Cape-based biotech company will see increased manufacturing of plant-based proteins used for testing for diseases. The grant is a shot in the arm for rolling out rapid diagnostic tests across South Africa and the continent. An almost R900 million investment in a Cape-based biotech company is a shot in the arm for rolling out rapid diagnostic tests across South Africa and the continent. The European Investment Bank and Foundation for Innovative New Diagnostics’ grant will help scale-up manufacturing of plant-based proteins needed for disease testing. eNCA;s Michael Appel reports. Courtesy #DStv403
